Opko Health, Inc. (NASDAQ:OPK) currently has a “Sell” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Hold” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.
Opko Health, Inc. (NASDAQ:OPK) gained 0.77 Percent and closed its previous trading session at $3.93. The stock traded with the average Volume of 4.75 Million at the end of last session.
Opko Health, Inc. (NASDAQ:OPK) has the Market Capitalization of 2.28 Billion. The Stock has its 52-week High of $8.92 and 52-Week Low of $3.61 and it touched its 52-week high on 02/21/17 and 52-Week Low on 02/09/18.
The company reported its last earnings Actual EPS of $-0.08/share. While, the analyst predicted that the company could provide an EPS of $-0.05/share. Hence the difference between Predicted EPS and Actual EPS reported is $-0.03/share which shows an Earnings Surprise of -60 Percent.
Sell side analysts plays vital role in buying and selling a stock where 2 analysts rated Opko Health, Inc. (NASDAQ:OPK) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -10.93% where SMA50 and SMA200 are -17.56% and -34.37% respectively.
The company shows its Return on Assets (ROA) value of -3.9%. The Return on Equity (ROE) value stands at -5.2%. While it’s Return on Investment (ROI) value is -0.8%.
Opko Health, Inc. (NASDAQ:OPK) currently has a Weekly Volatility of 6.21% percent while its Monthly Volatility is at 5.94% percent. While talking about Performance of the Stock, Opko Health, Inc. currently has a Weekly performance of -5.07%, monthly performance percentage is -14.57 percent, Quarterly performance is -25.29 percent, 6 months performance shows a percent value of -35.47% and Yearly Performance is -53.49 percent.
OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.